345MO IBI354 (Anti-Her2 Antibody-Drug Conjugate [ADC]) in Patients (pts) with Advanced Solid Tumors and Breast Cancer (BC): Results from a Phase I Study

C. Lemech, Y. Sun,A. Nagrial, X. Wu, M. Morris,F. Ning, J. Yang, Y. Pan, J. Cai, P. Lu, T. Zhang, F. Qiu, C. Hu, M. Zhang, Z. Liu, G. Han, J. Nie, C. Teng, H. Zhou, D. Day

Annals of Oncology（2024）

引用 0|浏览1